Şeyma Çalış
Şeyma Çalış
itu.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
PRKCA, PTPN1 and ZYX Are Possible Markers to Target CD133+ GBM Stem Cells
S Ozkanca, MG Bal, Y Yukselten, DA Yildiz, HC Ugur, K Demircan, ...
The FASEB Journal 30 (1_supplement), lb442-lb442, 2016
12016
PXN and TRIO are elevated in CD133+ GSCs transcriptomically
A Sunguroglu, M Bunsuz, Y Yukselten, MG Bal, S Ozkanca, DA Yildiz, ...
The FASEB Journal 30 (1_supplement), lb96-lb96, 2016
12016
Near-Physiological-Temperature Serial Femtosecond X-ray Crystallography Reveals Novel Conformations of SARS-CoV-2 Main Protease Active Site for Improved Drug Repurposing
S Durdagi, C Dag, B Dogan, M Yigin, T Avsar, C Buyukdag, I Erol, B Ertem, ...
bioRxiv, 2020
2020
Integrating Ligand and Target-Driven Based Virtual Screening Approaches With in vitro Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer Assay to …
G Tutumlu, B Dogan, T Avsar, MD Orhan, S Calis, S Durdagi
Frontiers in chemistry 8, 2020
2020
Effectiveness of Controlled MDM2 Inhibitor Release on Brain Tumor Cells in vitro
E Zengın, Ş Çaliş, T Avşar, S Önder
2019 Medical Technologies Congress (TIPTEKNO), 1-2, 2019
2019
Lomeguatrib, a O-6-Methylguanine-DNA-Methyltransferase (MGMT) Inhibitor, Induces DNA Damage Induced Apoptosis By Targeting Double-Strand DNA Repair in Multiple Myeloma
DA Yildiz, T Ozkan, Y Yukselten, NT Sesli, S Ozkanca, M Gunduz, M Ozen, ...
BLOOD 128 (22), 2016
2016
The Role of BCAR1 and FYN on CD133+ GBM stem cells
Y Yukselten, MG Bal, S Ozkanca, DA Yildiz, M Bunsuz, HC Ugur, ...
The FASEB Journal 30 (1_supplement), lb98-lb98, 2016
2016
Status of INSR, LRP1 and VCL transcripts on CD133+ Glioblastoma Multiforme Stem Cells
MG Bal, Y Yukselten, S Ozkanca, E Akgün, HC Ugur, A Sunguroglu
The FASEB Journal 30 (1_supplement), lb443-lb443, 2016
2016
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–8